Pharmaceutical Pipelines
Companies developing cardiometabolic therapies
AbbVie
Akero Therapeutics
Altimmune
Amgen
Amylyx Pharmaceuticals
Ascletis Pharma
Astellas Pharma
AstraZeneca
Bayer
Beijing Dongfang Biotech
Beijing QL Biopharmaceutical
Biogen
Biomed Industries
Bioneurals
BioNTech
Boehringer Ingelheim
BrightGene Bio-Medical Technology
Bristol Myers Squibb
Carmot Therapeutics
Chia Tai Tianqing Pharmaceutical Group
CSPC Pharmaceutical Group
Eli Lilly and Company
Fortrea Clinical Research Unit
Fujian Shengdi Pharmaceutical
Gan & Lee Pharmaceuticals
Gasherbrum Bio
Gilead Sciences
GSK
Guangdong Raynovent Biotech
Hangzhou Sciwind Biosciences
Hangzhou Zhongmei Huadong Pharmaceutical
Hanmi Pharmaceutical
Helicore Biopharma
Hoffmann-La Roche
Immunwork
Innovent Biologics
Jiangsu Hansoh Pharmaceutical
Jiangsu HengRui Medicine
Johnson & Johnson
Lexicon Pharmaceuticals
Merck Sharp & Dohme LLC
Metsera
MindRank AI
Moderna
Neuraly
NeuroBo Pharmaceuticals
Novartis
Novo Nordisk A/S
Pfizer
Profil Institut für Stoffwechselforschung
Quotient Sciences
RANI Therapeutics
Regeneron Pharmaceuticals
Regor Pharmaceuticals
REMD Biotherapeutics
Rose Pharma Inc
Sanofi
Shanghai Minwei Biotechnology
Structure Therapeutics
Takeda Pharmaceutical
Terns Pharmaceuticals
Vertex Pharmaceuticals
Viking Therapeutics
YUNOVIA
Zealand Pharma
Click on a company to view their drug development pipeline and clinical trial data.